Your browser doesn't support javascript.
loading
Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG.
Haist, Maximilian; Stege, Henner; Rogall, Friederike; Tan, Yuqi; von Wasielewski, Imke; Klespe, Kai Christian; Meier, Friedegund; Mohr, Peter; Kähler, Katharina C; Weichenthal, Michael; Hauschild, Axel; Schadendorf, Dirk; Ugurel, Selma; Lodde, Georg; Zimmer, Lisa; Gutzmer, Ralf; Debus, Dirk; Schilling, Bastian; Kreuter, Alexander; Ulrich, Jens; Meiss, Frank; Herbst, Rudolf; Forschner, Andrea; Leiter, Ulrike; Pfoehler, Claudia; Kaatz, Martin; Ziller, Fabian; Hassel, Jessica C; Tronnier, Michael; Sachse, Michael; Dippel, Edgar; Terheyden, Patrick; Berking, Carola; Heppt, Markus V; Kiecker, Felix; Haferkamp, Sebastian; Gebhardt, Christoffer; Simon, Jan Christoph; Grabbe, Stephan; Loquai, Carmen.
  • Haist M; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany Maximilian.Haist@unimedizin-mainz.de.
  • Stege H; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
  • Rogall F; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Tan Y; Department of Dermatology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • von Wasielewski I; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA.
  • Klespe KC; Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
  • Meier F; Skin Cancer Center Hannover, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
  • Mohr P; Department of Dermatology, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Kähler KC; Skin Cancer Center, National Center for Tumor Diseases, Dresden, Germany.
  • Weichenthal M; Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany.
  • Hauschild A; Department of Dermatology, Skin Cancer Center, University Hospital Schleswig-Holstein - Campus Kiel, Kiel, Germany.
  • Schadendorf D; Department of Dermatology, Skin Cancer Center, University Hospital Schleswig-Holstein - Campus Kiel, Kiel, Germany.
  • Ugurel S; Department of Dermatology, Skin Cancer Center, University Hospital Schleswig-Holstein - Campus Kiel, Kiel, Germany.
  • Lodde G; Department of Dermatology, Venerology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany.
  • Zimmer L; Department of Dermatology, Venerology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany.
  • Gutzmer R; Department of Dermatology, Venerology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany.
  • Debus D; Department of Dermatology, Venerology and Allergology, University Hospital Essen and German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany.
  • Schilling B; Department of Dermatology, Muelenkreiskliniken Minden and Ruhr University Bochum, Minden, Germany.
  • Kreuter A; Department of Dermatology, Nuremberg Hospital, Nurnberg, Germany.
  • Ulrich J; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany.
  • Meiss F; Department of Dermatology, Venerology and Allergology, Helios St. Elisabeth Klinik Oberhausen, University Witten-Herdecke, Oberhausen, Germany.
  • Herbst R; Department of Dermatology and Allergy, Harzklinikum Dorothea Christiane Erxleben GmbH, Quedlinburg, Germany.
  • Forschner A; Department of Dermatology and Venerology, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Germany.
  • Leiter U; Department of Dermatology, HELIOS Hospital Erfurt, Erfurt, Germany.
  • Pfoehler C; Center for Dermatooncology, Department of Dermatology, Eberhard-Karls University of Tübingen, Tubingen, Germany.
  • Kaatz M; Center for Dermatooncology, Department of Dermatology, Eberhard-Karls University of Tübingen, Tubingen, Germany.
  • Ziller F; Department of Dermatology, Saarland University Hospital and Saarland University Faculty of Medicine, Homburg, Germany.
  • Hassel JC; Department of Dermatology, DRK Hospital Chemnitz-Rabenstein, Rabenstein, Germany.
  • Tronnier M; Department of Dermatology, DRK Hospital Chemnitz-Rabenstein, Chemnitz, Germany.
  • Sachse M; National Center for Tumor Diseases (NCT), Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Dippel E; Department of Dermatology, HELIOS Hospital Hildesheim, Hildesheim, Germany.
  • Terheyden P; Department of Dermatology, Hospital Bremerhaven Reinkenheide, Bremerhaven, Germany.
  • Berking C; Department of Dermatology, Ludwigshafen City Hospital, Ludwigshafen, Germany.
  • Heppt MV; Department of Dermatology, Allergology and Venerology, University Medical Center Schleswig Holstein Lübeck Campus, Lubeck, Germany.
  • Kiecker F; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Haferkamp S; Comprehensive Cancer Center, Uniklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Gebhardt C; Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Simon JC; Comprehensive Cancer Center, Uniklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Grabbe S; Department of Dermatology, Vivantes Hospital Neukölln, Berlin, Germany.
  • Loquai C; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
J Immunother Cancer ; 11(9)2023 09.
Article en En | MEDLINE | ID: mdl-37730278
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article